Effect of peptide Vilon on the content of transforming growth factor-[beta] and permeability of microvessels during experimental chronic renal failure

Effect of peptide Vilon on the content of transforming growth factor-[beta] and permeability of microvessels during experimental chronic renal failure

We studied the effect of Vilon in rats 2, 4, and 6 months after the onset of chronic renal failure. Subcutaneous injection of Vilon significantly decreased serum concentration of transforming growth factor-β1 and permeability of mesenteric microvessels in rats 2 months after the onset of chronic ren...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Bulletin of experimental biology and medicine 2005-01, Vol.139 (1), p.24
Hauptverfasser: Gavrisheva, N A, Malinin, V V, Ses', T P, Kozlov, K L, Panchenko, A V, A. Yu. Titkov
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 1
container_start_page 24
container_title Bulletin of experimental biology and medicine
container_volume 139
creator Gavrisheva, N A
Malinin, V V
Ses', T P
Kozlov, K L
Panchenko, A V
A. Yu. Titkov
description We studied the effect of Vilon in rats 2, 4, and 6 months after the onset of chronic renal failure. Subcutaneous injection of Vilon significantly decreased serum concentration of transforming growth factor-β1 and permeability of mesenteric microvessels in rats 2 months after the onset of chronic renal failure. Our results indicate that the preparation produces a potent homeostatic effect in the early period of chronic renal failure.
doi_str_mv 10.1007/s10517-005-0202-9
format Article
fullrecord <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_journals_213368365</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>839057461</sourcerecordid><originalsourceid>FETCH-proquest_journals_2133683653</originalsourceid><addsrcrecordid>eNqNjN1KxDAQhYO4YHV9AO8G76NJa3-8lhUfQPZGZMmmk22WNKmT1J8X8XlNxQcQBobD-b7D2JUUN1KI9jZKUcuWC1FzUYqS35-wQtZtxbuylKesEBnid13XnbHzGI9LFI0s2PfGGNQJgoEJp2R7hK11wUO-NCDo4BP63z6R8tEEGq0_wIHCRxrAKJ0C8Zc9JvUKyvd5hUZUe-ts-lqs0WoK7xgjugj9TIuMn5myY95VDvRAwVsNhD4no6ybCddsZZSLePn3L9j14-b54YlPFN5mjGl3DDNlIe5KWVVNVzV19S_oBzYeYCc</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>213368365</pqid></control><display><type>article</type><title>Effect of peptide Vilon on the content of transforming growth factor-[beta] and permeability of microvessels during experimental chronic renal failure</title><source>SpringerNature Journals</source><creator>Gavrisheva, N A ; Malinin, V V ; Ses', T P ; Kozlov, K L ; Panchenko, A V ; A. Yu. Titkov</creator><creatorcontrib>Gavrisheva, N A ; Malinin, V V ; Ses', T P ; Kozlov, K L ; Panchenko, A V ; A. Yu. Titkov</creatorcontrib><description>We studied the effect of Vilon in rats 2, 4, and 6 months after the onset of chronic renal failure. Subcutaneous injection of Vilon significantly decreased serum concentration of transforming growth factor-β1 and permeability of mesenteric microvessels in rats 2 months after the onset of chronic renal failure. Our results indicate that the preparation produces a potent homeostatic effect in the early period of chronic renal failure.</description><identifier>ISSN: 0007-4888</identifier><identifier>EISSN: 1573-8221</identifier><identifier>DOI: 10.1007/s10517-005-0202-9</identifier><identifier>CODEN: BEXBAN</identifier><language>eng</language><publisher>New York: Springer Nature B.V</publisher><ispartof>Bulletin of experimental biology and medicine, 2005-01, Vol.139 (1), p.24</ispartof><rights>Springer Science+Business Media, Inc. 2005</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Gavrisheva, N A</creatorcontrib><creatorcontrib>Malinin, V V</creatorcontrib><creatorcontrib>Ses', T P</creatorcontrib><creatorcontrib>Kozlov, K L</creatorcontrib><creatorcontrib>Panchenko, A V</creatorcontrib><creatorcontrib>A. Yu. Titkov</creatorcontrib><title>Effect of peptide Vilon on the content of transforming growth factor-[beta] and permeability of microvessels during experimental chronic renal failure</title><title>Bulletin of experimental biology and medicine</title><description>We studied the effect of Vilon in rats 2, 4, and 6 months after the onset of chronic renal failure. Subcutaneous injection of Vilon significantly decreased serum concentration of transforming growth factor-β1 and permeability of mesenteric microvessels in rats 2 months after the onset of chronic renal failure. Our results indicate that the preparation produces a potent homeostatic effect in the early period of chronic renal failure.</description><issn>0007-4888</issn><issn>1573-8221</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNqNjN1KxDAQhYO4YHV9AO8G76NJa3-8lhUfQPZGZMmmk22WNKmT1J8X8XlNxQcQBobD-b7D2JUUN1KI9jZKUcuWC1FzUYqS35-wQtZtxbuylKesEBnid13XnbHzGI9LFI0s2PfGGNQJgoEJp2R7hK11wUO-NCDo4BP63z6R8tEEGq0_wIHCRxrAKJ0C8Zc9JvUKyvd5hUZUe-ts-lqs0WoK7xgjugj9TIuMn5myY95VDvRAwVsNhD4no6ybCddsZZSLePn3L9j14-b54YlPFN5mjGl3DDNlIe5KWVVNVzV19S_oBzYeYCc</recordid><startdate>20050101</startdate><enddate>20050101</enddate><creator>Gavrisheva, N A</creator><creator>Malinin, V V</creator><creator>Ses', T P</creator><creator>Kozlov, K L</creator><creator>Panchenko, A V</creator><creator>A. Yu. Titkov</creator><general>Springer Nature B.V</general><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>8AO</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope></search><sort><creationdate>20050101</creationdate><title>Effect of peptide Vilon on the content of transforming growth factor-[beta] and permeability of microvessels during experimental chronic renal failure</title><author>Gavrisheva, N A ; Malinin, V V ; Ses', T P ; Kozlov, K L ; Panchenko, A V ; A. Yu. Titkov</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_journals_2133683653</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gavrisheva, N A</creatorcontrib><creatorcontrib>Malinin, V V</creatorcontrib><creatorcontrib>Ses', T P</creatorcontrib><creatorcontrib>Kozlov, K L</creatorcontrib><creatorcontrib>Panchenko, A V</creatorcontrib><creatorcontrib>A. Yu. Titkov</creatorcontrib><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>Bulletin of experimental biology and medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gavrisheva, N A</au><au>Malinin, V V</au><au>Ses', T P</au><au>Kozlov, K L</au><au>Panchenko, A V</au><au>A. Yu. Titkov</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effect of peptide Vilon on the content of transforming growth factor-[beta] and permeability of microvessels during experimental chronic renal failure</atitle><jtitle>Bulletin of experimental biology and medicine</jtitle><date>2005-01-01</date><risdate>2005</risdate><volume>139</volume><issue>1</issue><spage>24</spage><pages>24-</pages><issn>0007-4888</issn><eissn>1573-8221</eissn><coden>BEXBAN</coden><abstract>We studied the effect of Vilon in rats 2, 4, and 6 months after the onset of chronic renal failure. Subcutaneous injection of Vilon significantly decreased serum concentration of transforming growth factor-β1 and permeability of mesenteric microvessels in rats 2 months after the onset of chronic renal failure. Our results indicate that the preparation produces a potent homeostatic effect in the early period of chronic renal failure.</abstract><cop>New York</cop><pub>Springer Nature B.V</pub><doi>10.1007/s10517-005-0202-9</doi></addata></record>
fulltext fulltext
identifier ISSN: 0007-4888
ispartof Bulletin of experimental biology and medicine, 2005-01, Vol.139 (1), p.24
issn 0007-4888
1573-8221
language eng
recordid cdi_proquest_journals_213368365
source SpringerNature Journals
title Effect of peptide Vilon on the content of transforming growth factor-[beta] and permeability of microvessels during experimental chronic renal failure
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-20T01%3A45%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effect%20of%20peptide%20Vilon%20on%20the%20content%20of%20transforming%20growth%20factor-%5Bbeta%5D%20and%20permeability%20of%20microvessels%20during%20experimental%20chronic%20renal%20failure&rft.jtitle=Bulletin%20of%20experimental%20biology%20and%20medicine&rft.au=Gavrisheva,%20N%20A&rft.date=2005-01-01&rft.volume=139&rft.issue=1&rft.spage=24&rft.pages=24-&rft.issn=0007-4888&rft.eissn=1573-8221&rft.coden=BEXBAN&rft_id=info:doi/10.1007/s10517-005-0202-9&rft_dat=%3Cproquest%3E839057461%3C/proquest%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=213368365&rft_id=info:pmid/&rfr_iscdi=true